VR Logo

Lupin Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1983

Chairman: Manju D Gupta

Managing Director: Nilesh Gupta

Group: Lupin

Listing: NSE: LUPIN, BSE: 500257

Headquarters: Mumbai, Maharashtra

Website: www.lupinworld.com

Key Facts

Market cap: R 43,698.13 Cr

Revenue (TTM): R 15,502.52 Cr

Earnings (TTM): R -467.33 Cr

Cash: R 4,792.55 Cr

Total Debt: R 6,305.32 Cr

Promoters' ownership: 46.91%

Liquidity: High

52 Week range: R 504.75 - 1,122.30

Face value: R2.00

Shares outstanding: 45,32,76,636

10 Years Aggregate:

  • CFO: 15,963.08 Cr
  • EBITDA: 27,984.10 Cr
  • Net Profit: 12,835.09 Cr

Stock Performance

Time Period Lupin S&P BSE Sensex S&P BSE Healthcare
YTD25.93-2.6944.23
1 month-3.467.37-0.19
3 months12.775.2913.39
1 Year31.012.7749.84
3 Years-1.146.5911.64
5 Years-14.037.961.22
10 Years8.107.0911.52
As on 26-Oct-2020
Year Lupin S&P BSE Sensex S&P BSE Healthcare
2019-9.2714.38-3.55
2018-4.595.87-5.89
2017-40.4827.910.49
2016-19.421.95-12.88
201528.55-5.0315.06
201455.8029.8947.43
201347.748.9822.55